{{2-[Carboxymethyl-(2-{carboxymethyl-[(2-chloro-4-sulfamoyl-phenylcarbamoyl)-methyl]-amino}-ethyl)-amino]-ethyl}-[(2-chloro-4-sulfamoyl-phenylcarbamoyl)-methyl]-amino}-acetic acid

InChIKey	`FDQVIZWYDGHVRY-UHFFFAOYSA-N`
Compound Name	{{2-[Carboxymethyl-(2-{carboxymethyl-[(2-chloro-4-sulfamoyl-phenylcarbamoyl)-methyl]-amino}-ethyl)-amino]-ethyl}-[(2-chloro-4-sulfamoyl-phenylcarbamoyl)-methyl]-amino}-acetic acid
Canonical SMILES	`NS(=O)(=O)c1ccc(NC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)Nc2ccc(S(N)(=O)=O)cc2Cl)CC(=O)O)CC(=O)O)c(Cl)c1`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	4
Pfam Stratification	Cross-Family
Avg pChEMBL	7.5
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P00918	CA2	Homo sapiens	Human	PF00194	7.8	Ki	ChEMBL;BindingDB
P18505	GABRB1	Homo sapiens	Human	PF02931 PF02932	7.8	pIC50	TTD_MultiTarget
P22748	CA4	Homo sapiens	Human	PF00194	7.6	Ki	ChEMBL;BindingDB
P00915	CA1	Homo sapiens	Human	PF00194	6.8	Ki	ChEMBL;BindingDB